Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Share Capital

v3.21.1
Note 10 - Share Capital
 3 Months Ended
Mar. 31, 2021
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
10.
 Share capital:
 
The Company has authorized share capital of an unlimited number of common voting shares.
 
(a)
 Equity issuances:
 
2020
At-The-Market (“ATM”) Facility
 
On
May 5, 2020,
the Company entered into an equity distribution agreement with Piper Sandler and Canaccord Genuity acting as co-agents in connection with the
2020
ATM Facility. Under the terms of the
2020
ATM Facility, the Company
may,
from time to time, sell Common Shares having an aggregate offering value of up to
$75
million through Piper Sandler and Canaccord Genuity on the Nasdaq Capital Market. During the year ended
December 31, 2020
and in the
first
quarter ended
March 21, 2021,
the Company did
not
issue any shares under the
2020
ATM Facility.
 
(b)
 Loss per share:
 
Loss per common share is calculated using the weighted average number of common shares outstanding and is presented in the table below:
 
    Three months ended
March 31, 2021		     Three months ended
March 31, 2020		  
             
Net loss   $
(16,227
 )   $
(11,526
 )
Weighted-average common shares – basic and diluted    
88,884
      
76,227
  
Net loss per share – basic and diluted   $
(0.18
 )   $
(0.15
 )
 
The effect of any potential exercise of the Company's stock options outstanding during the
three
month periods ended
March 31, 2021
and
March 31, 2020
has been excluded from the calculation of diluted loss per common share as it would be anti-dilutive.